Holoclara
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
PO Box 515381 pmb 24549, Los Angeles, Ca...Website
www.holoclara.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Holoclara
Holoclara is the first biotechnology company to create safe, orally available worm-derived therapies designed to provide relief to millions of people living with allergic and autoimmune disease. Founded and led by physician-scientist Andrea Choe, Holoclara mines potent immunomodulatory molecules from gut roundworms, building upon decades of preclinical data proving their therapeutic efficacy across a wide range of diseases. With a team of world-renowned experts in worm biology and biotechnology and the backing of leading life sciences and technology investors, Holoclara is uniquely positioned to harness the therapeutic potential of worms to address historically untreatable diseases.Explore more
Holoclara Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Holoclara your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Holoclara
Funding: Get notified immidiatlly once Holoclara has new funding data
Check if Holoclara has recently received funding, and reach out quickly before it becomes old news!
Click to see if Holoclara had a recent Job posting/layoffs
Holoclara, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Holoclara launches new products
Earning: See what the market has to say on Holoclara recently announced quarterly report
Check out if Holoclara is spiking on competitors!
Recommended Actions
Find VP level buyers at Holoclara
Find 3 more new buyers
Company Profile Activity
Activity Insights
Holoclara is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Holoclara is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Holoclara.
Holoclara financials insights
Gather financial insights about Holoclara, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series A
$16M
Holoclara Tech Stack
A closer look at the technologies used by Holoclara
See more technologies
Most Recent Scoops
Funding
Funding
Executive Move
Executive Moves, Board of Directors
Funding
Project
Funding
Project
Holoclara News & Media
Holoclara Selects Eosinophilic Esophagitis as its Lead Indication for HC002, a First-in-Class Worm-Derived Therapy
PASADENA, Calif.--(BUSINESS WIRE)--Holoclara selects eosinophilic esophagitis as its lead indication for HC002, a first-in-class worm-derived therapyHoloclara Announces $16 Million Series A Financing to Advance a Breakthrough Class of Worm-Derived Therapies for Allergic and Autoimmune Disease
PASADENA, Calif.--(BUSINESS WIRE)--Financing led by BOLD Capital Partners, alongside early investments from Horizons Ventures and participation from syndicate of leading angel investorsExclusive: Holoclara raises $16 million Series A to develop therapeutics—with worms
Holoclara has raised $16 million for its Series A, Fortune has exclusively learned. Bold Capital Partners led the round, with participation from Horizons Ventures, Tarrasque, Endurance28, Freeflow Ventures, and a number of angel investors.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Holoclara
Sign Up For FreeTo access detailed company insights
Holoclara is the first biotechnology company to create safe, orally available worm-derived therapies designed to provide relief to millions of people living with allergic and autoimmune disease. Founded and led by physician-scientist Andrea Choe, Holoclara mines potent immunomodulatory molecules from gut roundworms, building upon decades of preclin... Read More
